Scientists have leveraged fundamental features of chemical building blocks to transform chemical reaction analysis from minutes to milliseconds. The development of molecules to study and treat disease ...

Argobio Studio, the launch platform for Europe's best innovative science, today announced the successful seed financing of Enodia Therapeutics, a ...

Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at ...

Synfini, Inc., provider of the industry's most advanced Agile AI Foundry for drug discovery, today announced the launch of Fast Pass I, an open, rapid cloud workflow system which provides qualified ...

For Daniil Boiko and Andrei Tyrin, the idea for Onepot AI came from the same frustration. “The best ideas in drug discovery were often blocked not by biology, but by synthesis,” Boiko told TechCrunch.

Deerfield Management, Khosla Ventures, and Sofinnova Partners co-lead Series A fundraise for Excelsior Sciences to accelerate drug discovery and clinical development while supporting pharma reshoring.

Brings together Recursion’s scaled biology exploration and translational capabilities with Exscientia’s precision chemistry design and small molecule automated synthesis capabilities to create a ...

Howard Hughes Medical Institute scientists have simplified the chemical synthesis of small molecules, eliminating a major bottleneck that limits the exploration of a class of compounds offering ...

Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...

Daniel Blair, PhD, assistant member in the St. Jude Department of Chemical Biology and Therapeutics, and postdoctoral fellow Maowei Hu, PhD, at work in the lab. “Generality is essential for doing ...